STRM - Streamline Health Solutions Inc Stock Price, Fair Value and News

0.32USD0.00 (0.00%)Market Closed

Market Summary

USD0.320.00

Market Closed

0.00%

STRM Stock Price

View Fullscreen

STRM RSI Chart

STRM Valuation

Market Cap

20.9M

Price/Earnings (Trailing)

-1.12

Price/Sales (Trailing)

0.93

EV/EBITDA

-1.33

Price/Free Cashflow

-9.22

STRM Price/Sales (Trailing)

STRM Profitability

EBT Margin

-82.95%

Return on Equity

-99.38%

Return on Assets

-44.8%

Free Cashflow Yield

-10.85%

STRM Fundamentals

STRM Revenue

Revenue (TTM)

22.6M

Rev. Growth (Yr)

-20.52%

Rev. Growth (Qtr)

-12.59%

STRM Earnings

Earnings (TTM)

-18.7M

Earnings Growth (Yr)

37.21%

Earnings Growth (Qtr)

88.5%

Breaking Down STRM Revenue

Last 7 days

-3.0%

Last 30 days

-11.1%

Last 90 days

-39.6%

Trailing 12 Months

-80%

How does STRM drawdown profile look like?

STRM Financial Health

Current Ratio

0.65

Debt/Equity

Debt/Cashflow

-67.12

STRM Investor Care

Shares Dilution (1Y)

11.47%

Diluted EPS (TTM)

-0.33

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	22.6M	0	0	0
2023	24.9M	24.3M	24.1M	24.0M
2022	17.5M	20.4M	23.5M	24.2M
2021	11.3M	11.4M	0	14.1M
2020	11.9M	11.6M	0	11.5M
2019	22.4M	21.5M	21.0M	21.4M
2018	24.3M	24.7M	24.0M	23.0M
2017	27.1M	26.3M	24.9M	24.6M
2016	28.3M	28.8M	27.6M	27.0M
2015	27.6M	26.8M	28.2M	28.5M
2014	28.5M	29.0M	27.4M	27.5M
2013	23.8M	24.8M	28.5M	28.7M
2012	17.1M	18.4M	19.3M	21.5M
2011	17.6M	17.5M	17.4M	17.2M
2010	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

Tracking the Latest Insider Buys and Sells of Streamline Health Solutions Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 29, 2024	reeves bryant j iii	acquired	46,500	0.31	150,000	chief financial officer
Apr 29, 2024	lovvorn wendy l	acquired	46,500	0.31	150,000	chief people officer
Apr 29, 2024	stilwill benjamin louis	acquired	52,700	0.31	170,000	president and ceo
Feb 07, 2024	etheridge matthew	acquired	68,000	0.34	200,000	-
Dec 04, 2023	reeves bryant j iii	acquired	14,000	0.28	50,000	interim cfo
Nov 01, 2023	green wyche t iii	sold (taxes)	-2,135	0.43	-4,967	-
Nov 01, 2023	stilwill benjamin louis	sold (taxes)	-3,900	0.43	-9,072	president & ceo
Oct 31, 2023	gibson thomas j.	sold (taxes)	-9,901	0.43	-23,027	former chief financial officer
Oct 31, 2023	gibson thomas j.	back to issuer	-73,100	0.43	-170,000	former chief financial officer
Jun 15, 2023	phillips jonathan r	acquired	125,000	1.45	86,207	-

Which funds bought or sold STRM recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
May 15, 2024	STATE STREET CORP	reduced	-25.00	-7,513	41,625	-%
May 15, 2024	MORGAN STANLEY	reduced	-28.57	-2,875	12,000	-%
May 15, 2024	AMERIPRISE FINANCIAL INC	sold off	-100	-4,675	-	-%
May 15, 2024	FIRST MANHATTAN CO. LLC.	unchanged	-	29.00	253	-%
May 15, 2024	BANK OF AMERICA CORP /DE/	added	294	80.00	102	-%
May 15, 2024	TOWNSQUARE CAPITAL LLC	reduced	-63.15	-33,603	23,955	-%
May 15, 2024	HARBERT FUND ADVISORS, INC.	unchanged	-	265,332	2,315,620	1.59%
May 15, 2024	Tower Research Capital LLC (TRC)	reduced	-27.62	-1,517	6,793	-%
May 15, 2024	TWO SIGMA SECURITIES, LLC	reduced	-60.96	-6,265	4,942	-%
May 15, 2024	Royal Bank of Canada	reduced	-23.36	-	-	-%

Are Funds Buying or Selling STRM?

Are funds buying STRM calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own STRM

No. of Funds

Unveiling Streamline Health Solutions Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Sep 27, 2023	gci partners opportunity fund, lp	6.6%	3,917,082	SC 13G
Jun 22, 2023	tamarack advisers, lp	9.4%	5,514,515	SC 13D/A
Feb 03, 2023	marathon micro fund, lp	5.4%	3,097,380	SC 13G/A
Dec 01, 2022	tamarack advisers, lp	10.7%	5,128,308	SC 13D/A
Nov 01, 2022	pessin norman h	1.8%	981,284	SC 13D/A
Jul 11, 2022	marathon micro fund, lp	5.1%	2,500,000	SC 13G
Apr 14, 2022	gci partners opportunity fund, lp	6.0%	2,835,814	SC 13G
Feb 14, 2022	nantahala capital management, llc	0%	0	SC 13G/A
Aug 19, 2021	harbert discovery fund, lp	8.4%	3,966,637	SC 13D/A
Mar 23, 2021	tamarack advisers, lp	12.1%	5,036,063	SC 13D/A

Recent SEC filings of Streamline Health Solutions Inc

View All Filings

Date Filed	Form Type	Document
May 13, 2024	DEF 14A	DEF 14A
May 13, 2024	8-K	Current Report
May 07, 2024	S-3	S-3
May 01, 2024	4	Insider Trading
May 01, 2024	4	Insider Trading
May 01, 2024	4	Insider Trading
Apr 30, 2024	10-K	Annual Report
Apr 29, 2024	8-K	Current Report

Peers (Alternatives to Streamline Health Solutions Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	482.9B	379.5B	9.53%	9.48%	31.44	1.27	12.96%	-25.81%
CI	96.2B	206.0B	-2.11%	32.08%	24.97	0.47	12.55%	-43.95%
HCA	84.6B	66.7B	3.80%	15.55%	15.46	1.27	9.59%	-4.59%
CVS	72.4B	360.9B	-15.92%	-16.78%	9.89	0.2	9.07%	78.49%
CNC	41.7B	155.5B	8.44%	18.66%	15.24	0.27	6.34%	84.42%
DVA	12.3B	12.3B	9.53%	38.52%	15.03	0.99	5.77%	58.74%
UHS	11.9B	14.7B	11.04%	30.82%	14.63	0.81	7.99%	19.23%
MID-CAP
CHE	8.5B	2.3B	-6.47%	5.37%	30.15	3.73	5.96%	18.29%
ACHC	6.2B	3.0B	-5.49%	-7.73%	-545.12	2.06	10.92%	-104.06%
AMEH	2.3B	1.5B	9.06%	20.53%	36.62	1.57	19.34%	40.15%
AMN	2.2B	3.5B	4.01%	-38.44%	15.49	0.64	-27.67%	-62.43%
SMALL-CAP
ADUS	1.8B	1.1B	14.53%	25.72%	27.59	1.67	11.45%	30.74%
BKD	1.3B	3.0B	6.97%	85.25%	-7.66	0.44	4.98%	4.88%
BEAT	54.5M	-	-4.17%	-6.33%	-3.61	-	-	-1.05%
AMS	22.0M	21.6M	16.05%	23.93%	39.79	1.02	9.04%	-50.63%

Streamline Health Solutions Inc News

Latest updates

Streamline Health Solutions Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q2	2021Q1	2020Q4	2020Q2	2020Q1	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1	2018Q4
Revenue	-12.6%	5,361,000	6,133,000	5,770,000	5,332,000	6,745,000	6,217,000	5,992,000	5,935,000	6,046,000	5,514,000	2,951,000	2,974,000	2,641,000	2,844,000	3,825,333	4,806,667	5,788,000	4,793,000	5,357,000	5,464,000	5,369,000
Costs and Expenses	-66.1%	6,467,000	19,080,000	8,368,000	8,328,000	8,581,000	9,379,000	8,648,000	9,112,000	8,153,000	9,334,000	5,406,000	4,282,000	4,515,000	4,350,000	-	5,364,000	5,325,000	4,328,000	4,037,000	8,453,000	5,914,000
S&GA Expenses	-35.6%	2,653,000	4,122,000	4,107,000	3,806,000	3,723,500	4,055,000	3,934,000	4,501,000	3,425,000	3,439,000	2,551,000	1,706,500	2,283,000	2,291,000	-	2,021,000	2,762,000	2,402,000	2,421,000	2,393,000	2,392,000
R&D Expenses	6.9%	1,394,000	1,304,000	1,305,000	1,701,000	1,515,000	1,754,000	1,461,000	1,312,000	1,502,000	1,339,000	977,000	987,000	753,000	684,000	-	940,000	501,000	660,000	589,000	-611,500	1,026,000
EBITDA Margin	0.3%	-0.59	-0.59	-0.23	-0.26	-0.25	-0.06	-0.17	-0.10	-0.16	-0.57	-0.60	-0.52	-0.67	-	-	-	-	-	-	-	-
Interest Expenses	9.0%	290,000	266,000	267,000	248,000	230,000	198,000	189,000	132,000	129,000	85,000	13,000	12,000	12,000	14,000	-	70,000	91,000	70,000	78,000	52,000	106,000
Income Taxes	110.8%	13,000	-120,000	8,000	53,000	49,000	9,000	2,000	11,000	100,000	4,000	9,000	276,000	-803,000	-561,000	-	-497,500	-454,000	-356,000	-325,000	5,500	2,000
Earnings Before Taxes	88.7%	-1,357,000	-12,031,000	-2,507,000	-2,848,000	-2,133,000	-3,129,000	-3,270,000	-2,776,000	95,500	-4,375,000	-2,453,000	-1,314,000	-1,872,000	-1,538,000	-	-3,082,500	-1,977,000	-2,012,000	-642,000	-3,102,000	-676,000
EBT Margin	-1.9%	-0.83	-0.81	-0.44	-0.47	-0.45	-0.38	-0.44	-0.35	-0.39	-0.58	-0.61	-0.53	-0.68	-	-	-	-	-	-	-	-
Net Income	88.5%	-1,370,000	-11,911,000	-2,515,000	-2,901,000	-2,182,000	-3,138,000	-3,272,000	-2,787,000	-30,000	-4,310,000	-2,142,000	-1,187,000	-1,055,000	3,673,000	-	-2,404,000	-164,000	-608,000	313,000	-3,097,000	-678,000
Net Income Margin	-1.7%	-0.83	-0.81	-0.45	-0.47	-0.46	-0.38	-0.44	-0.35	-0.37	-0.55	-0.48	0.03	-0.08	-	-	-	-	-	-	-	-
Free Cashflow	95.0%	-61,000	-1,225,000	-1,080,000	97,000	-2,422,000	-1,770,000	-1,704,000	-1,293,000	115,000	-2,500,000	-480,000	188,000	-1,720,000	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	1.5%	42.00	41.00	53.00	56.00	62.00	62.00	57.00	60.00	62.00	62.00	38.00	40.00	26.00	25.00	28.00	29.00	32.00	31.00	32.00	32.00	32.00
Current Assets	14.5%	9.00	8.00	9.00	12.00	16.00	17.00	11.00	14.00	15.00	15.00	20.00	22.00	7.00	5.00	8.00	9.00	7.00	5.00	7.00	8.00	8.00
Cash Equivalents	24.8%	3.00	3.00	4.00	6.00	7.00	12.00	6.00	8.00	10.00	10.00	16.00	17.00	2.00	3.00	6.00	7.00	2.00	1.00	1.00	2.00	2.00
Net PPE	-6.4%	0.00	0.00	-	-	0.00	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Goodwill	0%	13.00	13.00	23.00	23.00	23.00	23.00	23.00	23.00	23.00	23.00	11.00	11.00	11.00	11.00	11.00	11.00	11.00	16.00	16.00	16.00	16.00
Liabilities	7.3%	23.00	21.00	22.00	23.00	26.00	28.00	28.00	29.00	28.00	29.00	7.00	9.00	8.00	7.00	9.00	9.00	16.00	13.00	17.00	17.00	17.00
Current Liabilities	7.9%	14.00	13.00	13.00	14.00	17.00	19.00	15.00	15.00	14.00	7.00	7.00	9.00	7.00	6.00	8.00	7.00	16.00	13.00	13.00	12.00	12.00
Long Term Debt	-	-	-	-	-	-	-	-	-	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	-	-	-	-	-
LT Debt, Current	-	2.00	-	1.00	1.00	1.00	1.00	1.00	0.00	0.00	0.00	-	2.00	2.00	1.00	1.00	1.00	4.00	3.00	1.00	1.00	1.00
Shareholder's Equity	-4.7%	19.00	20.00	31.00	33.00	36.00	34.00	29.00	31.00	34.00	34.00	31.00	31.00	17.00	18.00	19.00	20.00	16.00	18.00	6.00	7.00	6.00
Retained Earnings	-1.2%	-115	-114	-102	-99.90	-97.04	-94.86	-91.72	-85.66	-85.66	-85.63	-81.32	-81.26	-79.12	-77.93	-76.87	-75.74	-79.41	-77.01	-76.84	-76.24	-76.55
Additional Paid-In Capital	0.3%	134	133	133	132	132	128	120	119	119	119	112	111	96.00	96.00	96.00	95.00	95.00	95.00	83.00	83.00	83.00
Accumulated Depreciation	4.7%	0.00	0.00	0.00	0.00	0.00	-	-	-	0.00	0.00	0.00	0.00	0.00	-	-	-	0.00	2.00	2.00	2.00	2.00
Shares Outstanding	0.3%	59.00	59.00	59.00	59.00	58.00	48.00	47.00	47.00	48.00	46.00	41.00	37.00	32.00	-	-	-	-	-	-	-	-
Float	-	-	-	57.00	-	-	-	-	-	-	-	48.00	-	-	-	26.00	-	-	-	23.00	-	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	95.6%	-54.00	-1,225	-1,062	126	-2,422	-1,770	-1,681	-1,270	138	-2,485	-1,059	-478	190	-1,712	-68.00	-1,903	-417	-2,217	-1,591	-1,484	2,105
Share Based Compensation	1074.2%	705	60.00	537	572	468	555	331	326	557	537	557	565	374	442	349	263	215	290	160	269	137
Cashflow From Investing	97.8%	-12.00	-536	-640	-433	-490	-564	-362	-519	-549	-12,711	469	-378	-291	-409	-645	10,805	-662	-601	-761	-828	-714
Cashflow From Financing	202.6%	699	231	-198	-304	-2,189	8,115	6.00	-141	-87.00	9,788	-166	14,614	-576	-610	-36.00	-1,721	91.00	1,912	840	-152	-159

Get Full Access to Grufity – and Unlimited Downloads

Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.

Try For Just $1.99

STRM Income Statement

2024-01-31

Consolidated Statements of Operations - USD ($)

12 Months Ended

Jan. 31, 2024

Jan. 31, 2023

Revenues:

Total revenues

$ 22,596,000

$ 24,889,000

Operating expenses:

Cost of software as a service

6,573,000

6,358,000

Cost of maintenance and support

315,000

427,000

Cost of professional fees and licenses

4,165,000

6,610,000

Selling, general and administrative expense

14,710,000

16,283,000

Research and development

5,704,000

6,042,000

Impairment of goodwill

9,813,000

Impairment of long-lived assets

963,000

Total operating expenses

42,243,000

35,720,000

Operating loss

(19,647,000)

(10,831,000)

Other income (expense):

Interest expense

(1,071,000)

(749,000)

Acquisition earnout valuation adjustments

1,944,000

71,000

Other

31,000

201,000

Loss before income taxes

(18,743,000)

(11,308,000)

Income tax benefit (expense)

46,000

(71,000)

Net loss

$ (18,697,000)

$ (11,379,000)

Basic Earnings Per Share

$ (0.33)

$ (0.23)

Diluted Earnings Per Share

$ (0.33)

$ (0.23)

Weighted average number of common shares - basic

^[1]

56,510,419

49,324,858

Weighted average number of common shares - diluted

56,510,419

49,324,858

Softwareas As A Service [Member]

Revenues:

Total revenues

$ 14,075,000

$ 12,326,000

Maintenance And Support [Member]

Revenues:

Total revenues

4,318,000

4,483,000

Professional Fees And Licenses [Member]

Revenues:

Total revenues

$ 4,203,000

$ 8,080,000

[1]	Excludes the effect of unvested restricted shares of common stock, which are considered non-participating securities. As of January 31, 2024 and 2023, there were 1,970,521 and 1,848,031 unvested restricted shares of common stock, respectively.

STRM Balance Sheet

2024-01-31

Consolidated Balance Sheets - USD ($)	Jan. 31, 2024	Jan. 31, 2023
Current assets:
Cash and cash equivalents	$ 3,190,000	$ 6,598,000
Accounts receivable, net of allowance for credit losses of $86,000 and $132,000, respectively	4,237,000	7,719,000
Contract receivables	780,000	960,000
Prepaid and other current assets	629,000	710,000
Total current assets	8,836,000	15,987,000
Non-current assets:
Property and equipment, net of accumulated amortization of $291,000 and $246,000 respectively	88,000	79,000
Right-of use asset for operating lease		32,000
Capitalized software development costs, net of accumulated amortization of $7,960,000 and $6,224,000, respectively	5,798,000	5,846,000
Intangible assets, net of accumulated amortization of $4,019,000 and $2,627,000, respectively	12,071,000	14,793,000
Goodwill	13,276,000	23,089,000
Other	1,666,000	1,695,000
Total non-current assets	32,899,000	45,534,000
Total assets	41,735,000	61,521,000
Current liabilities:
Accounts payable	1,253,000	626,000
Accrued expenses	2,023,000	3,265,000
Current portion of term loan	1,500,000	750,000
Deferred revenues	7,112,000	8,361,000
Operating lease obligations		35,000
Acquisition earnout liability	1,794,000	3,738,000
Total current liabilities	13,682,000	16,775,000
Non-current liabilities:
Term loan, net of deferred financing costs	7,566,000	8,964,000
Line of credit	1,500,000
Deferred revenues, less current portion	173,000	167,000
Other non-current liabilities		104,000
Total non-current liabilities	9,239,000	9,235,000
Total liabilities	22,921,000	26,010,000
Commitments and contingencies – Note 12
Stockholders’ equity
Common stock, $0.01 par value per share, 85,000,000 shares authorized; 58,945,498 and 57,567,210 shares issued and outstanding, respectively	590,000	576,000
Additional paid in capital	133,923,000	131,973,000
Accumulated deficit	(115,699,000)	(97,038,000)
Total stockholders’ equity	18,814,000	35,511,000
Total liabilities and stockholders’ equity	$ 41,735,000	$ 61,521,000

About Streamline Health Solutions Inc

Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in the United States and Canada. The company offers RevID, an automated revenue reconciliation software; eValuator, a coding analysis platform; data comparison engine; coding and clinical documentation improvement (CDI) solutions, including CDI, abstracting, and physician query; and financial management solutions, such as accounts receivable management, denials management, claims processing, spend management, and audit management. It also provides auditing and coding, software, and professional services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.

CEO	Mr. Wyche T. Green III
WEBSITE	streamlinehealth.net
INDUSTRY	Healthcare Plans
EMPLOYEES	112

Streamline Health Solutions Inc Frequently Asked Questions

What is the ticker symbol for Streamline Health Solutions Inc? What does STRM stand for in stocks?

STRM is the stock ticker symbol of Streamline Health Solutions Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Streamline Health Solutions Inc (STRM)?

As of Fri May 17 2024, market cap of Streamline Health Solutions Inc is 20.92 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of STRM stock?

You can check STRM's fair value in chart for subscribers.

What is the fair value of STRM stock?

You can check STRM's fair value in chart for subscribers. The fair value of Streamline Health Solutions Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Streamline Health Solutions Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for STRM so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Streamline Health Solutions Inc a good stock to buy?

The fair value guage provides a quick view whether STRM is over valued or under valued. Whether Streamline Health Solutions Inc is cheap or expensive depends on the assumptions which impact Streamline Health Solutions Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for STRM.

What is Streamline Health Solutions Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri May 17 2024, STRM's PE ratio (Price to Earnings) is -1.12 and Price to Sales (PS) ratio is 0.93. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. STRM PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Streamline Health Solutions Inc's stock?

In the past 10 years, Streamline Health Solutions Inc has provided -0.242 (multiply by 100 for percentage) rate of return.